Aaron Dy, PhD 👨🏻‍🔬🏃🏻‍♂️

10.2K posts

Aaron Dy, PhD 👨🏻‍🔬🏃🏻‍♂️ banner
Aaron Dy, PhD 👨🏻‍🔬🏃🏻‍♂️

Aaron Dy, PhD 👨🏻‍🔬🏃🏻‍♂️

@AaronJDy

BD @Relay_Tx. Science nerd, biotech guy, distance runner, country music fan, Hoosier in Boston. Ex- @DanaFarber @HealthAdvances @MITdeptofBE he/him 🇵🇭🇺🇸

Boston, MA Katılım Mart 2009
1.1K Takip Edilen1.9K Takipçiler
Aaron Dy, PhD 👨🏻‍🔬🏃🏻‍♂️ retweetledi
Relay Therapeutics
Relay Therapeutics@Relay_Tx·
Today, we announced that the US FDA has granted zovegalisib Breakthrough Therapy Designation for PIK3CA-mutant, HR+/HER2- advanced #breastcancer, supported by data from our ReDiscover trial testing zovegalisib at the 600mg BID fasted & 400mg BID fed doses in combo w/ fulvestrant.
Relay Therapeutics tweet media
English
2
4
12
1.1K
Aaron Dy, PhD 👨🏻‍🔬🏃🏻‍♂️ retweetledi
Indiana Football
Indiana Football@IndianaFootball·
Perfection.
Indiana Football tweet media
English
570
4.5K
22.2K
1M
Aaron Dy, PhD 👨🏻‍🔬🏃🏻‍♂️ retweetledi
SportsCenter
SportsCenter@SportsCenter·
"We won the national championship at Indiana University, it can be done." Indiana Football head coach Curt Cignetti with @MollyAMcGrath after beating Miami 👏
English
254
2.4K
31.6K
1.1M
Aaron Dy, PhD 👨🏻‍🔬🏃🏻‍♂️ retweetledi
Relay Therapeutics
Relay Therapeutics@Relay_Tx·
We will present our preclinical work in #vascularmalformations at #VAC2025 today. As we advance our commitment to innovation, we’re preparing to initiate the Phase 1 clinical trial of RLY-2608 in PI3Kα-driven vascular malformations by the end of Q1. Congratulations Fabien & team!
Relay Therapeutics tweet media
English
0
2
11
2K
BHC
BHC@brianhc·
@AaronJDy Congrats! We're 3 months ahead of you. Exciting times!
English
1
0
1
29
Aaron Dy, PhD 👨🏻‍🔬🏃🏻‍♂️
Would recommend to anyone looking at grad school opportunities around the interface of engineering and biology. Not sure everyone can say this about their PhD program, but I truly enjoyed my time @MITdeptofBE!
Jessica Stark@JessicaCStark

We are accepting applications to join our 2025 PhD cohort at @MITdeptofBE! Learn more about the program, application process, and opportunities for application assistance below. Please share with junior scientists interested in the interface of #biology and #engineering! 🧫🧬🧑‍🔬

English
0
0
5
389
Aaron Dy, PhD 👨🏻‍🔬🏃🏻‍♂️ retweetledi
Relay Therapeutics
Relay Therapeutics@Relay_Tx·
Today, we announced positive interim data for RLY-2608 demonstrating clinically meaningful progression free survival for RLY-2608 in patients with HR+/HER2- #BreastCancer. President of R&D Dr. Don Bergstrom shares more about the significance of these data below. Tune into our conference call this morning, September 9, at 8:00AM ET for details. $RLAY ir.relaytx.com/news-releases/…
Relay Therapeutics tweet media
English
1
5
16
3.7K
Aaron Dy, PhD 👨🏻‍🔬🏃🏻‍♂️ retweetledi
Relay Therapeutics
Relay Therapeutics@Relay_Tx·
🧵 (1/9) Today, beginning at 8AM, we will be live tweeting from our New Program & Platform Event. Check back here for real-time details on our new program disclosures and other exciting updates. See this morning’s press release and register for our live webcast here. ir.relaytx.com/events/event-d… $RLAY
Relay Therapeutics tweet media
English
1
3
12
2.5K
Aaron Dy, PhD 👨🏻‍🔬🏃🏻‍♂️ retweetledi
Relay Therapeutics
Relay Therapeutics@Relay_Tx·
Today, we announced a clinical trial collaboration to develop RLY-2608 with atirmociclib, Pfizer’s next-generation selective CDK4 inhibitor currently in Phase 1 studies, in triplet combination in patients with PI3Kα-mutated, HR+, HER2-metastatic #breastcancer. Clinical start by YE 2024. Find full details here. ir.relaytx.com/news-releases/… $RLAY
Relay Therapeutics tweet media
English
0
5
11
3.8K
Aaron Dy, PhD 👨🏻‍🔬🏃🏻‍♂️ retweetledi
Indiana Fever
Indiana Fever@IndianaFever·
Generational. Welcome to Basketball Country, Caitlin Clark.
English
343
4.5K
22.7K
2.8M
Aaron Dy, PhD 👨🏻‍🔬🏃🏻‍♂️ retweetledi
Julia Joung
Julia Joung@JuliaJoung·
Our review on the latest and greatest CRISPR technologies for genome, epigenome and transcriptome editing is now online @NatRevMCB! We cover recent CRISPR engineering strategies and clinical applications rdcu.be/dxDD9
English
1
32
134
23.8K